Education
About Us
Working with TipRanks
Follow Us
Richard Peters Insider Profile
4 Followers
Richard Peters, President & CEO, Director at Merrimack Pharmaceuticals, holds ― shares in Merrimack Pharmaceuticals (Ticker: MACK), holds 0.00 shares in Kineta (Ticker: KANT), holds 3.12K shares in Aprea Therapeutics (Ticker: APRE). Most recently, Richard Peters ― shares of Merrimack Pharmaceuticals on ― for an estimated value of ―.
Richard Peters Merrimack Pharmaceuticals (MACK)President & CEO, Director
Merrimack Pharmaceuticals (MACK)
President & CEO, Director
Ranked #43,547 out of 105,390 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+5.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Richard Peters holds in companies
Most Profitable Insider Trade
Stock:
Kineta
(KANT)
(KANT)
Rating:Informative Sell
Date:Jul 06, 2022 - Jul 06, 2023
Return:+24.60%
The most profitable trade made by Richard Peters
Richard Peters's Trading History
Merrimack Pharmaceuticals
―
―
―
―
Aprea Therapeutics
Jun 09, 2025
Director
Uninformative Buy
―
$2.97K
Kineta
Jul 02, 2025
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Richard Peters's performance on stock
You May Also Like
Richard Peters insider profile FAQ
What is the percentage of profitable transactions made by Richard Peters?
The percentage of profitable transactions made by Richard Peters is 67%.
What is the average return per transaction made by Richard Peters?
The average return per transaction made by Richard Peters is 5.00%.
What stocks does Richard Peters hold?
Richard Peters holds: MACK, APRE, KANT stocks.
What was Richard Peters’s latest transaction?
Richard Peters latest transaction was an Uninformative Buy of ―.
What was Richard Peters's most profitable transaction?
Richard Peters’s most profitable transaction was an Informative Sell of KANT stock on July 6, 2022. The return on the trade was 24.60%.
What is Richard Peters's role in Merrimack Pharmaceuticals?
Richard Peters's role in Merrimack Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.